Experimental priapism is associated with increased oxidative stress and activation of protein degradation pathways in corporal tissue

International Journal of Impotence Research

Volumn 22, Issue 6, 2010, Pages 363-373

  Kanika, N D ^a   Melman, A ^a   Davies, K P ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

lipid peroxidation; opiorphin; oxidative stress; priapism; sickle cell disease; ubiquination

Indexed keywords

CELL PROTEIN; GLUTATHIONE TRANSFERASE; LIGASE; PROTEIN BCL 2; PROTEIN MDM2; UBIQUITIN PROTEIN LIGASE NEDD4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORPUS CAVERNOSUM; ENZYME ACTIVITY; LIPID PEROXIDATION; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIAPISM; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RAT; SICKLE CELL ANEMIA; UBIQUITINATION; UPREGULATION;

ANEMIA, SICKLE CELL; ANIMALS; DISEASE MODELS, ANIMAL; GLUTATHIONE TRANSFERASE; LIPID PEROXIDATION; MALE; MICE; MICE, TRANSGENIC; OLIGOPEPTIDES; OXIDATION-REDUCTION; OXIDATIVE STRESS; PENIS; PRIAPISM; PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, SPRAGUE-DAWLEY; SALIVARY PROTEINS AND PEPTIDES; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 78650605529     PISSN: 09559930     EISSN: 14765489     Source Type: Journal    
DOI: 10.1038/ijir.2010.27     Document Type: Article

References (62)

1. Montague DK, Jarow J, Broderick GA, Dmochowski RR, Heaton JP, Lue TF et al. American Urological Association guideline on the management of priapism. J Urol 2003; 170(4 Part 1): 1318-1324.
2. El-Bahnasawy MS, Dawood A, Farouk A. Low-flow priapism: Risk factors for erectile dysfunction. BJU Int 2002; 89: 285-290.
3. Pryor J, Akkus E, Alter G, Jordan G, Lebret T, Levine L et al. Priapism. J Sex Med 2004; 1: 116-120.
4. Bennett N, Mulhall J. Sickle cell disease status and outcomes of African-American men presenting with priapism. J Sex Med 2008; 5: 1244-1250.
5. Sood S, JamesW, Bailon MJ. Priapism associated with atypical antipsychotic medications: A review. Int Clin Psychopharmacol 2008; 23: 9-17.
6. Nunes KP, Costa-Goncalves A, Lanza LF, Cortes SF, Cordeiro MN, Richardson M et al. Tx2-6 toxin of the Phoneutria nigriventer spider potentiates rat erectile function. Toxicon 2008; 51: 1197-1206.
7. Fowler Jr JE, Koshy M, Strub M, Chinn SK. Priapism associated with the sickle cell hemoglobinopathies: Prevalence, natural history and sequelae. J Urol 1991; 145: 65-68.
8. Emond AM, Holman R, Hayes RJ, Serjeant GR. Priapism and impotence in homozygous sickle cell disease. Arch Intern Med 1980; 140: 1434-1437.
9. Kanika ND, Tar M, Tong Y, Kuppam DS, Melman A, Davies KP. The mechanism of opiorphin-induced experimental priapism in rats involves activation of the polyamine synthetic pathway. Am J Physiol Cell Physiol 2009; 297: C916-C927.
10. Tong Y, Tar M, Melman A, Davies K. The opiorphin gene (ProL1) and its homologues function in erectile physiology. BJU Int 2008; 102: 736-740.
11. Tong Y, Tar M, Davelman F, Christ G, Melman A, Davies KP. Variable coding sequence protein A1 as a marker for erectile dysfunction. BJU Int 2006; 98: 396-401.
12. Burnett AL, Chang AG, Crone JK, Huang PL, Sezen SE. Noncholinergic penile erection in mice lacking the gene for endothelial nitric oxide synthase. J Androl 2002; 23: 92-97.
13. Champion HC, Bivalacqua TJ, Takimoto E, Kass DA, Burnett AL. Phosphodiesterase-5A dysregulation in penile erectile tissue is a mechanism of priapism. Proc Natl Acad Sci USA 2005; 102: 1661-1666.
14. Mi T, Abbasi S, Zhang H, Uray K, Chunn JL, Xia LW et al. Excess adenosine in murine penile erectile tissues contributes to priapism via A2B adenosine receptor signaling. J Clin Invest 2008; 118: 1491-1501.
15. Morris CR. Mechanisms of vasculopathy in sickle cell disease and thalassemia. Hematology Am Soc Hematol Educ Program 2008; 1: 177-185.
16. Kato GJ, Gladwin MT, Steinberg MH. Deconstructing sickle cell disease: Reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Rev 2007; 21: 37-47.
17. Hsu LL, Champion HC, Campbell-Lee SA, Bivalacqua TJ, Manci EA, Diwan BA et al. Hemolysis in sickle cell mice causes pulmonary hypertension due to global impairment in nitric oxide bioavailability. Blood 2007; 109: 3088-3098.
18. Morris CR, Kato GJ, Poljakovic M, Wang X, Blackwelder WC, Sachdev V et al. Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. JAMA 2005; 294: 81-90.
19. Durante W, Johnson FK, Johnson RA. Arginase: A critical regulator of nitric oxide synthesis and vascular function. Clin Exp Pharmacol Physiol 2007; 34: 906-911.
20. Yuan J, Desouza R, Westney OL, Wang R. Insights of priapism mechanism and rationale treatment for recurrent priapism. Asian J Androl 2008; 10: 88-101.
21. Burnett AL. Molecular pharmacotherapeutic targeting of PDE5 for preservation of penile health. J Androl 2008; 29: 3-14.
22. Dai Y, Zhang Y, Phatarpekar P, Mi T, Zhang H, Blackburn MR et al. Adenosine signaling, priapism and novel therapies. J Sex Med 2009; 6(Suppl 3): 292-301.
23. Jeremy JY, Angelini GD, Khan M, Mikhailidis DP, Morgan RJ, Thompson CS et al. Platelets, oxidant stress and erectile dysfunction: An hypothesis. Cardiovasc Res 2000; 46: 50-54.
24. Azadzoi KM, Schulman RN, Aviram M, Siroky MB. Oxidative stress in arteriogenic erectile dysfunction: Prophylactic role of antioxidants. J Urol 2005; 174: 386-393.
25. 2-* and improves erectile function in aged rats. Am J Physiol Heart Circ Physiol 2003; 284: H1408-H1421.
26. Deng W, Bivalacqua TJ, Champion HC, Hellstrom WJ, Murthy SN, Kadowitz PJ. Superoxide dismutase-a target for gene therapeutic approach to reduce oxidative stress in erectile dysfunction. Methods Mol Biol 2010; 610: 213-227.
27. Jones RW, Rees RW, Minhas S, Ralph D, Persad RA, Jeremy JY. Oxygen free radicals and the penis. Expert Opin Pharmacother 2002; 3: 889-897.
28. Bivalacqua TJ, Usta MF, Kendirci M, Pradhan L, Alvarez X, Champion HC et al. Superoxide anion production in the rat penis impairs erectile function in diabetes: Influence of in vivo extracellular superoxide dismutase gene therapy. J Sex Med 2005; 2: 187-197; discussion 197-8.
29. Agarwal A, Nandipati KC, Sharma RK, Zippe CD, Raina R. Role of oxidative stress in the pathophysiological mechanism of erectile dysfunction. J Androl 2006; 27: 335-347.
30. Evliyaoglu Y, Kayrin L, Kaya B. Effect of pentoxifylline on veno-occlusive priapism-induced corporeal tissue lipid peroxidation in a rat model. Urol Res 1997; 25: 143-147. (Pubitemid 27166166)
31. Evliyaoglu Y, Kayrin L, Kaya B. Effect of allopurinol on lipid peroxidation induced in corporeal tissue by veno-occlusive priapism in a rat model. Br J Urol 1997; 80: 476-479.
32. Tong Y, Tar M, Monrose V, DiSanto M, Melman A, Davies KP. hSMR3A as a marker for patients with erectile dysfunction. J Urol 2007; 178: 338-343.
33. Habig WH, Pabst MJ, Jakoby WB. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 1974; 249: 7130-7139.
34. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351-358.
35. Melman A, Biggs G, Davies K, ZhaoW, TarMT, Christ GJ. Gene transfer with a vector expressing Maxi-K from a smooth muscle-specific promoter restores erectile function in the aging rat. Gene Therapy 2008; 15: 364-370.
36. Melman A, Zhao W, Davies KP, Bakal R, Christ GJ. The successful long-term treatment of age related erectile dysfunction with hSlo cDNA in rats in vivo. J Urol 2003; 170: 285-290.
37. Mizushima N, Yoshimori T. How to interpret LC3 immunoblotting. Autophagy 2007; 3: 542-545.
38. Ezaki J, Kominami E. The intracellular location and function of proteins of neuronal ceroid lipofuscinoses. Brain Pathol 2004; 14: 77-85.
39. Plant PJ, Correa J, Goldenberg N, Bain J, Batt J. The inositol phosphatase MTMR4 is a novel target of the ubiquitin ligase Nedd4. Biochem J 2009; 419: 57-63.
40. Lin HK, Wang L, Hu YC, Altuwaijri S, Chang C. Phosphorylation-dependent ubiquitylation and degradation of androgen receptor by Akt require Mdm2 E3 ligase. EMBO J 2002; 21: 4037-4048.
41. Hsu L, Diwan B,Ward JM, Noguchi CT. Pathology of 'Berkeley' sickle-cell mice includes gallstones and priapism. Blood 2006; 107: 3414-3415.
42. Kanika ND, Tar M, Tong Y, Kuppam DS, Melman A, Davies KP. The mechanism of opiorphin-induced experimental priapism in rats involves activation of the polyamine synthetic pathway. Am J Physiol Cell Physiol 2009; 297: C916-C927.
43. Claudino MA, Franco-Penteado CF, Corat MA, Gimenes AP, Passos LA, Antunes E et al. Increased cavernosal relaxations in sickle cell mice priapism are associated with alterations in the NO-cGMP signaling pathway. J Sex Med 2009; 6: 2187-2196.
44. Bivalacqua TJ, Musicki B, Hsu LL, Gladwin MT, Burnett AL, Champion HC. Establishment of a Transgenic Sickle-Cell Mouse Model to Study the Pathophysiology of Priapism. J Sex Med 2009; 6: 2494-2504.
45. Hockenbery DM, Oltvai ZN, Yin XM, Milliman CL, Korsmeyer SJ. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993; 75: 241-251.
46. Kane DJ, Sarafian TA, Anton R, Hahn H, Gralla EB, Valentine JS et al. Bcl-2 inhibition of neural death: Decreased generation of reactive oxygen species. Science 1993; 262: 1274-1277.
47. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and ugly. Am J Physiol 1996; 271(5 Part 1): C1424-C1437.
48. Khan MA, Thompson CS, Mumtaz FH, Mikhailidis DP, Morgan RJ, Bruckdorfer RK et al. The effect of nitric oxide and peroxynitrite on rabbit cavernosal smooth muscle relaxation. World J Urol 2001; 19: 220-224.
49. Kaul DK, Zhang X, Dasgupta T, Fabry ME. Arginine therapy of transgenic-knockout sickle mice improves microvascular function by reducing non-nitric oxide vasodilators, hemolysis, and oxidative stress. Am J Physiol Heart Circ Physiol 2008; 295: H39-H47.
50. Kaul DK, Liu XD, Chang HY, Nagel RL, Fabry ME. Effect of fetal hemoglobin on microvascular regulation in sickle transgenic-knockout mice. J Clin Invest 2004; 114: 1136-1145.
51. Friguet B. Oxidized protein degradation and repair in ageing and oxidative stress. FEBS Lett 2006; 580: 2910-2916.
52. Gonzalez-Cadavid NF. Mechanisms of penile fibrosis. J Sex Med 2009; 6(Suppl 3): 353-362.
53. Melman A, Gingell JC. The epidemiology and pathophysiology of erectile dysfunction. J Urol 1999; 161: 5-11.
54. Kovanecz I, Ferrini MG, Vernet D, Nolazco G, Rajfer J, Gonzalez-Cadavid NF. Pioglitazone prevents corporal venoocclusive dysfunction in a rat model of type 2 diabetes mellitus. BJU Int 2006; 98: 116-124.
55. Ferrini MG, Davila HH, Kovanecz I, Sanchez SP, Gonzalez-Cadavid NF, Rajfer J. Vardenafil prevents fibrosis and loss of corporal smooth muscle that occurs after bilateral cavernosal nerve resection in the rat. Urology 2006; 68: 429-435.
56. Gonzalez-Cadavid NF, Rajfer J. Molecular pathophysiology and gene therapy of aging-related erectile dysfunction. Exp Gerontol 2004; 39: 1705-1712.
57. Hebbel RP, Eaton JW, Balasingam M, Steinberg MH. Spontaneous oxygen radical generation by sickle erythrocytes. J Clin Invest 1982; 70: 1253-1259.
58. Neidlinger NA, Larkin SK, Bhagat A, Victorino GP, Kuypers FA. Hydrolysis of phosphatidylserine-exposing red blood cells by secretory phospholipase A2 generates lysophosphatidic acid and results in vascular dysfunction. J Biol Chem 2006; 281: 775-781.
59. Krajewski ML, Hsu LL, Gladwin MT. The proverbial chicken or the egg? Dissection of the role of cell-free hemoglobin versus reactive oxygen species in sickle cell pathophysiology. Am J Physiol Heart Circ Physiol 2008; 295: H4-H7.
60. Kawakami T, Urakami S, Hirata H, Tanaka Y, Nakajima K, Enokida H et al. Superoxide dismutase analog (Tempol: 4-hydroxy-2, 2, 6, 6-tetramethylpiperidine 1-oxyl) treatment restores erectile function in diabetes-induced impotence. Int J Impot Res 2009; 21: 348-355.
61. Muneer A, Cellek S, Ralph DJ, Minhas S. The investigation of putative agents, using an in vitro model, to prevent cavernosal smooth muscle dysfunction during low-flow priapism. BJU Int 2008; 102: 988-992.
62. Ferrini MG, Kovanecz I, Sanchez S, Vernet D, Davila HH, Rajfer J et al. Long-term continuous treatment with sildenafil ameliorates aging-related erectile dysfunction and the underlying corporal fibrosis in the rat. Biol Reprod 2007; 76: 915-923.